Grant ID RP200401
Awarded On February 19, 2020
Title Targeting MEK in EGFR-Amplified Glioblastoma
Program Academic Research
Award Mechanism Individual Investigator
Institution/Organization The University of Texas M.D. Anderson Cancer Center
Principal Investigator/Program Director John de Groot
Cancer Sites Brain and Other Nervous System
Contracted Amount $900,000*

*Pending contract negotiation

Lay Summary

The median survival for patients with recurrent glioblastoma is six to nine months highlighting the need for better therapeutic strategies for this deadly disease. The revolution in cancer genomics has identified multiple amplification events as potential targets for therapeutic intervention in many cancers including glioblastoma. Multiple factors such as incorrect patient selection, inadequate drug delivery across the blood brain barrier, acquired resistance and drug-target heterogeneity may all lead to clinical failure of targeted therapies. Through an unbiased high-throughput screen utilizing our glioma stem-like cells (GSCs) we discovered that glioblastoma cells harboring focal EGFR ampl...

Read More